Development of Nanocarrier Based Formulation for Effective Treatment of Topical Fungal Infection

Abstract

This research presents the development and evaluation of nanostructured lipid carriers for enhanced antifungal therapy against Candida species. Nanostructured lipid carriers were successfully formulated using a high-shear homogenization technique, optimization of lipid composition and surfactant concentration to achieve stable nanoscale dispersions with desirable physicochemical properties was performed by design of experimentation. These carriers were subsequently incorporated into a topical gel matrix to facilitate localized drug delivery. Comprehensive in vitro release studies demonstrated drug release from the nanostructure lipid carrier loaded gel, indicating its potential for prolonged therapeutic action. Antifungal efficacy was assessed through microbiological assays, revealing significant inhibition of Candida growth compared to conventional formulations. Finally, in vivo studies were conducted on Wistar rats to evaluate therapeutic performance and safety. The NLC gel exhibited good antifungal activity, reduced fungal burden, and improved skin recovery, with no observable adverse effects. newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced